ArticleFuture oncology (London, England)2023

Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.

Ryan T Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.